Unraveling the Mystery of Long COVID: The Role of Co-Infections
For many individuals grappling with long COVID, symptoms like breathlessness, fatigue, and brain fog persist, leaving them searching for answers. A groundbreaking study by a team of microbiologists offers a compelling theory that could shed light on this enigmatic condition.
The researchers propose that long COVID symptoms may be linked to additional infections that occur alongside SARS-CoV-2. This hypothesis is supported by a comprehensive review published in eLife, involving 17 experts, including researchers from Rutgers Health.
Maria Laura Gennaro, a microbiologist at Rutgers New Jersey Medical School, highlights a crucial aspect often overlooked in discussions about long COVID. She emphasizes the potential impact of co-infections acquired before or during the COVID-19 illness, which could contribute to the persistent symptoms experienced by many.
The Growing Evidence of Other Pathogens
Long COVID has affected an estimated 400 million people worldwide, causing a range of issues from mild discomfort to severe disability. It affects multiple systems, including the brain, heart, lungs, and digestive system. Despite its widespread impact, effective treatments remain elusive due to the lack of a clear understanding of its underlying causes.
The recent review synthesizes existing scientific findings and expert opinions to bring attention to a lesser-known concept: the potential role of infections other than the coronavirus itself in contributing to long COVID.
EBV Reactivation: A Leading Suspect
One of the most compelling pieces of evidence points to the Epstein-Barr virus (EBV), the virus responsible for mononucleosis. Approximately 95% of adults carry EBV in a latent state, which typically remains dormant unless triggered by an immune challenge, such as COVID-19.
In an early study, researchers found that two-thirds of long COVID patients exhibited markers of recent EBV activity, and those with more severe symptoms had higher antibody levels. Subsequent studies further linked EBV reactivation with well-documented long COVID symptoms, including fatigue and cognitive difficulties.
TB and Immune Disruption
Another pathogen gaining attention is tuberculosis (TB). Around one-quarter of the global population carries latent TB. Evidence suggests that COVID-19 may reduce the immune cells that normally contain TB, increasing the risk of its reactivation. The relationship may also be bidirectional, as TB appears to worsen COVID-19 outcomes.
The researchers stress the importance of timing. Infections that occur before COVID-19 may weaken the immune system, infections during the initial illness may exacerbate tissue damage, and infections that arise after recovery could exploit lingering immune dysfunction caused by COVID-19.
Rising Rates of Other Diseases and 'Immunity Theft'
According to the authors, 44 countries have witnessed a tenfold increase in at least 13 infectious diseases compared to pre-pandemic levels. They introduce the concept of 'immunity theft,' suggesting that an acute COVID-19 episode may leave individuals more susceptible to other infections.
If co-infections indeed contribute to long COVID, existing treatments could be repurposed to target these underlying infections. Antibiotics and antivirals, for instance, might be utilized to address specific co-infections, and clinical trials could explore whether treating these infections alleviates long COVID symptoms.
A Hypothesis in Need of Further Proof
The researchers acknowledge that their hypothesis is still preliminary. While the connections they propose are biologically plausible, they have not been definitively proven. No causal relationship has been established between any co-infection and long COVID.
Gennaro emphasizes the importance of not drawing conclusions based on correlation alone. She states, 'Correlation doesn't equal causation.' Verifying the hypothesis would require extensive epidemiological studies and animal research, which are complicated by the lack of reliable animal models for long COVID.
Expanding the Search for Solutions
The authors express hope that their findings will stimulate further investigation into the role of co-infections in long COVID. Although the review does not offer immediate solutions for those currently suffering from long-term symptoms, the researchers suggest that effective treatment may require considering the coronavirus and co-infections together.
